Arseus NV (RCUS.BR)

RCUS.BR on Brussels Stock Exchange

21.95EUR
11:35am EDT
Price Change (% chg)

€2.12 (+10.69%)
Prev Close
€19.83
Open
€20.73
Day's High
€22.44
Day's Low
€20.73
Volume
494,244
Avg. Vol
55,596
52-wk High
€22.44
52-wk Low
€12.28

RCUS.BR

Chart for RCUS.BR

About

Arseus NV is a Belgium-based company that provides products and services for professionals and institutions active in the healthcare sector in Europe, South America and the United States. Its activities are subdivided into three divisions: Fagron is a supplier of pharmaceutical preparations for pharmacists according to... (more)

Overall

Beta: 0.57
Market Cap (Mil.): €621.84
Shares Outstanding (Mil.): 31.36
Dividend: 0.45
Yield (%): 2.27

Financials

  RCUS.BR Industry Sector
P/E (TTM): 14.12 27.94 37.87
EPS (TTM): 1.40 -- --
ROI: 11.15 9.18 18.70
ROE: 19.16 12.46 19.53
Search Stocks

UPDATE 2-Medical supplies group Arseus optimistic on second-half

* Says starts strategic review of two units (Adds detail on strategic review, share reaction, analyst comment)

6:40am EDT

Arseus H1 profit beats expectations led by drug ingredients

BRUSSELS, Aug 2 - Belgian medical equipment maker Arseus posted better-than-expected core profit in the first half of 2013, led by a surge in profitability at its Fagron unit which sells medical ingredients to pharmacies.

1:46am EDT

BRIEF-Arseus : Arseus divests Belgium based Dorge Medic

BRUSSELS, July 4 - Arseus NV : * Arseus divests Belgium based Dorge Medic

04 Jul 2013

Drug compounding supplier Arseus buys U.S.-based Freedom Pharma

BRUSSELS - Belgium-based Arseus , the world's biggest supplier of ingredients to pharmacists so they can mix up their own versions of drugs, bought U.S.-based Freedom Pharmaceuticals for an undisclosed sum, it said on Thursday.

25 Apr 2013

Drug compounding supplier Arseus buys U.S.-based Freedom Pharma

BRUSSELS, April 25 - Belgium-based Arseus , the worlds biggest supplier of ingredients to pharmacists so they can mix up their own versions of drugs, bought U.S.-based Freedom Pharmaceuticals for an undisclosed sum, it said on Thursday.

25 Apr 2013

Drug ingredient firm Arseus says Q1 sales rise

BRUSSELS, April 9 - Belgo-Dutch medical firm Arseus said on Tuesday growth in its drug ingredients business offset declines in its dental business in the first quarter.

09 Apr 2013

Drug ingredient firm Arseus says margins to improve in 2013

BRUSSELS, Feb 6 - Belgo-Dutch medical firm Arseus , the world's biggest seller of drug ingredients to pharmacists, expects its profit margin to improve this year after it beat profit expectations in 2012, it said on Wednesday.

06 Feb 2013

Earnings vs. Estimates

Search Stocks